Supplementary Figure S2 from Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Supplementary Figure S2. Progression-free survival probability of the patients treated within the GEIS-32 clinical trial, according to the 7 gene-based score. Time is defined in months.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Sarcoma Diagnosis and Treatment
Lymphoma Diagnosis and Treatment
Publication details
- Publication date
- 1 April 2026
- Language
- EN